Celldex Therapeutics, Inc. (CLDX) has a market capitalization of $2.22B and trades at $33.33. The 52-week range is 14.4-34.52.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.5, Earnings Per Share (EPS) of $-3.90, annual revenue of $1.5M.
The stock has a beta of 1.20, operates in the Healthcare sector.
